| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |